Comparison Between Fimasartan Versus Other Angiotensin Receptor Blockers in Patients With Heart Failure After Acute Myocardial Infarction.

Jihoon Kim Tae-Seok Seo Sung Eun Kim Hyejeong Park Taek Kyu Park Joo-Myung Lee Jeong Hoon Yang Young Bin Song Jin Ho Choi Seung-Hyuk Choi Hyeon Cheol Gwon Eliseo Guallar Juhee Cho Joo-Yong Hahn

Published in: Journal of Korean medical science (2023)

In this nationwide cohort, fimasartan, compared with other ARBs, had comparable treatment effects for a composite of all-cause death, recurrent MI, hospitalization for heart failure, and stroke in patients with heart failure after MI.

Keyphrases

acute myocardial infarction
heart failure
angiotensin converting enzyme
atrial fibrillation
left ventricular
angiotensin ii
percutaneous coronary intervention
cross sectional
combination therapy
acute coronary syndrome
replacement therapy
smoking cessation